Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
AVADEL Pharmaceuticals Plc (AVDL)  
$15.99 0.00 (0.00%) as of 4:30 Fri 4/12


Download
   
Exchange: Nasdaq National Market
Security Type: ADR
Shares Out: 58,240,000
Market Cap: 931.26(M)
Last Volume: 115,349 Avg Vol: 115,027
52 Week Range: $9.64 - $17.22
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Delivery

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Avadel Pharmaceuticals is a biopharmaceutical company. Co.'s primary product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in narcolepsy patients. Co.'s commercial products are: Akovaz, which is indicated for the treatment of hypotension occurring in the setting of anesthesia; Bloxiverz, which is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; and Vazculep®, which is for the treatment of hypotension occuring in the setting of anesthesia; and Nouress, which is a sterile injectable product for use in the hospital setting.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 2,000 43,500 370,500
Total Buy Value $0 $29,000 $595,497 $1,422,084
Total People Bought 0 1 5 6
Total Buy Transactions 0 1 6 18
Total Shares Sold 0 75,000 103,975 103,975
Total Sell Value $0 $1,089,750 $1,522,364 $1,522,364
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 2 2
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 189
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mchugh Thomas S Chief Financial Officer   •       –      –    2024-01-16 4 B $14.50 $29,000 D/D 2,000 80,500 2.74 7%     
   Mccamish Mark Anthony Director   –       •      –    2023-12-28 4 AS $14.53 $1,089,750 I/I (75,000) 67,025 10%     
   Mchugh Thomas S Chief Financial Officer   •       –      –    2023-08-14 4 B $14.45 $28,900 D/D 2,000 78,500 2.74 -3%     
   Mccamish Mark Anthony Director   –       •      –    2023-08-11 4 S $14.93 $432,614 I/I (28,975) 142,025 2%     
   Divis Greg J Chief Executive Officer   •       •      –    2023-08-10 4 B $13.20 $131,997 D/D 10,000 159,100 2.81 3%     
   Glass Geoffrey Michael Director   –       •      –    2023-08-10 4 B $13.40 $187,600 I/I 14,000 59,000 2.1 3%     
   Ende Eric J Director   –       •      –    2023-05-18 4 B $13.93 $181,100 D/D 13,000 167,900 2.39 -21%     
   Palczuk Linda Director   –       •      –    2023-05-09 4 B $14.76 $36,900 D/D 2,500 52,400 2.39 -21%     
   Palczuk Linda Director   –       •      –    2022-12-23 4 B $7.20 $14,405 D/D 2,000 49,900 2.39 114%     
   Mchugh Thomas S Chief Financial Officer   •       –      –    2022-11-29 4 B $7.80 $39,000 D/D 5,000 76,500 2.74 21%     
   Ende Eric J Director   –       •      –    2022-11-22 4 B $7.80 $156,050 D/D 20,000 154,900 2.39 9%     
   Glass Geoffrey Michael Director   –       •      –    2022-06-01 4 B $2.14 $96,300 I/I 45,000 45,000 2.1 141%     
   Ende Eric J Director   –       •      –    2022-06-01 4 B $2.27 $45,496 D/D 20,000 134,900 2.39 141%     
   Glass Geoffrey Michael Director   –       •      –    2022-05-31 4/A B $2.14 $96,300 I/I 45,000 45,000 2.1     -
   Ende Eric J Director   –       •      –    2022-05-31 4 B $2.16 $32,394 D/D 15,000 114,900 2.39 173%     
   Ende Eric J Director   –       •      –    2022-05-27 4 B $2.45 $36,747 D/D 15,000 99,900 2.39 144%     
   Divis Greg J Chief Executive Officer   •       •      –    2022-05-27 4 B $2.05 $102,500 D/D 50,000 149,100 2.81 144%     
   Mchugh Thomas S Chief Financial Officer   •       –      –    2022-05-27 4 B $2.14 $106,895 D/D 50,000 71,500 2.74 144%     
   Palczuk Linda Director   –       •      –    2022-05-27 4 B $1.60 $16,000 D/D 10,000 47,900 2.39 144%     
   Thornton Peter Director   –       •      –    2022-05-27 4 B $1.69 $84,500 D/D 50,000 83,055 2.39 144%     
   Glass Geoffrey Michael Director   –       •      –    2020-12-21 4 GD $0.00 $0 D/D 18,600 47,100     -
   Mchugh Thomas S Chief Financial Officer   •       –      –    2020-09-18 4 B $6.00 $24,000 D/D 4,000 21,500 2.74 20%     
   Ende Eric J Director   –       •      –    2020-09-17 4 B $5.79 $98,376 D/D 17,000 84,900 2.39 24%     
   Mccamish Mark Anthony Director   –       •      –    2020-09-17 4 B $5.83 $305,250 I/I 52,398 171,000 2.1 24%     
   Mccamish Mark Anthony Director   –       •      –    2020-09-16 4 B $5.73 $679,969 I/I 118,602 118,602 2.1 30%     
  189 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us